CoChat

Serum from patients with chronic obstructive pulmonary disease induces senescence-related phenotype in bronchial epithelial cells

Open access
Kuźnar-Kamińska, Barbara, Mikuła-Pietrasik, Justyna, Witucka, Anna, Romaniuk, Aleksandra, Konieczna, Natalia, Rubiś, Błażej, Książek, Krzysztof, Tykarski, Andrzej, Batura-Gabryel, Halina · 2018 · Scientific Reports

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Chronic obstructive pulmonary disease (COPD) is a risk factor for the development of lung cancer (LC). The mechanism of interplay between both diseases remains poorly recognized. This report examines whether COPD may cause a senescence response in human bronchial epithelial cells (HBECs), leading to the progression of LC in a senescence-dependent manner. The results show that HBECs exposed to serum from COPD patients manifest increased expression of markers of cellular senescence, including senescence-associated β-galactosidase (SA-β-Gal), histone γ-H2A.X, and p21, as compared to the serum of healthy donors. This effect coincides with an increased generation of reactive oxygen species by these cells. The clinical analysis demonstrated that COPD may cause the senescence, independently on smoking status and disease severity. The concentrations of CXCL5, CXCL8/IL-8 and VEGF were higher in conditioned medium (CM) harvested from HBECs after exposure to COPD serum as compared to controls. In addition, CM treated with serum from COPD patients stimulated adhesion of A549 cancer cells to HBECs, as well as accelerating cancer cell proliferation and migration in vitro. Collectively, these findings indicate that COPD may induce senescence-like changes in HBECs and thus enhance some processes associated with the progression of lung cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-018-31037-w

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Effect of serum from COPD patients and healthy volunteers on: the percentage of SA-β-Gal positive cells (A) and the activity of SA-β-Gal (B). Panel (C) shows representative results of staining against SA-β-Gal (positive cells have green cytoplasm). The arrows indicate exemplary enlarged, hypertrophic, SA-β-Gal-positive cells. The number of positively stained cells was expressed as a percentage of 500 counted cells. The results are expressed as means ± SEM. The number of samples from each group is indicated in the brackets at the bottom of the graph. NS - nonstimulated cells; RFU - relative fluorescence units.
Figure 1 Effect of serum from COPD patients and healthy volunteers on: the percentage of SA-β-Gal positive cells (A) and the activity of SA-β-Gal (B). Panel (C) shows representative results of staining against SA-β-Gal (positive cells have green cytoplasm). The arrows indicate exemplary enlarged, hypertrophic, SA-β-Gal-positive cells. The number of positively stained cells was expressed as a percentage of 500 counted cells. The results are expressed as means ± SEM. The number of samples from each group is indicated in the brackets at the bottom of the graph. NS - nonstimulated cells; RFU - relative fluorescence units.CC BY · PubMed Central
Figure 2 Effect of serum from COPD patients and healthy volunteers on the percentage of histone γ-H2A.X positive cells (A) and the activity of histone γ-H2A.X (B). Panel (C) shows representative results of staining against γ-H2A.X (positive cells display green foci within the nuclei marked with DAPI). The number of positively stained cells was expressed as a percentage of 500 counted cells. The number of samples from each group is indicated in the brackets at the bottom of the graph. The results are expressed as means ± SEM. NS - non-stimulated cells; RFU - relative fluorescence units.
Figure 2 Effect of serum from COPD patients and healthy volunteers on the percentage of histone γ-H2A.X positive cells (A) and the activity of histone γ-H2A.X (B). Panel (C) shows representative results of staining against γ-H2A.X (positive cells display green foci within the nuclei marked with DAPI). The number of positively stained cells was expressed as a percentage of 500 counted cells. The number of samples from each group is indicated in the brackets at the bottom of the graph. The results are expressed as means ± SEM. NS - non-stimulated cells; RFU - relative fluorescence units.CC BY · PubMed Central
Figure 3 Effect of serum from COPD patients and healthy volunteers on the p21 level (A) and ROS production (B). The number of samples from each group is indicated in the brackets at the bottom of the graph. The results are expressed as means ± SEMs; RFU: relative fluorescence units.
Figure 3 Effect of serum from COPD patients and healthy volunteers on the p21 level (A) and ROS production (B). The number of samples from each group is indicated in the brackets at the bottom of the graph. The results are expressed as means ± SEMs; RFU: relative fluorescence units.CC BY · PubMed Central
Figure 4 Effect of serum from COPD patients and healthy volunteers on the activity of SA-β-Gal (A–C) and the activity of histone γ-H2A.X (D–F) depending on smoking status, stage of obstruction, and COPD group, respectively. The number of samples from each group is indicated in the brackets at the bottom of the graph. The results are expressed as means ± SEMs. HBECs - human bronchial epithelial cells; RFU: relative fluorescence units.
Figure 4 Effect of serum from COPD patients and healthy volunteers on the activity of SA-β-Gal (A–C) and the activity of histone γ-H2A.X (D–F) depending on smoking status, stage of obstruction, and COPD group, respectively. The number of samples from each group is indicated in the brackets at the bottom of the graph. The results are expressed as means ± SEMs. HBECs - human bronchial epithelial cells; RFU: relative fluorescence units.CC BY · PubMed Central
Figure 5 Effect of serum from COPD patients and healthy volunteers on the level of p21 (A–C) and the production of ROS (D–F) depending on smoking status, stage of obstruction, and COPD group, respectively. The number of samples from each group is indicated in the brackets at the bottom of the graph. The results are expressed as means ± SEMs; RFU: relative fluorescence units.
Figure 5 Effect of serum from COPD patients and healthy volunteers on the level of p21 (A–C) and the production of ROS (D–F) depending on smoking status, stage of obstruction, and COPD group, respectively. The number of samples from each group is indicated in the brackets at the bottom of the graph. The results are expressed as means ± SEMs; RFU: relative fluorescence units.CC BY · PubMed Central
Figure 6 Effect of serum from COPD patients and healthy volunteers on the secretion of VEGF (A) CXCL8/IL-8 (B) and CXCL5 (C) by bronchial epithelial cells. The number of samples from each group is indicated in the brackets at the bottom of the graph. The results are expressed as means ± SEMs. RFU: relative fluorescence units.
Figure 6 Effect of serum from COPD patients and healthy volunteers on the secretion of VEGF (A) CXCL8/IL-8 (B) and CXCL5 (C) by bronchial epithelial cells. The number of samples from each group is indicated in the brackets at the bottom of the graph. The results are expressed as means ± SEMs. RFU: relative fluorescence units.CC BY · PubMed Central
Figure 7 Effect of serum from COPD patients and healthy volunteers on the secretion of VEGF (A–C) CXCL8/IL-8 (D–F) and CXCL5 (G–I) depending on smoking status, stage of obstruction, and COPD group by bronchial epithelial cells, respectively. The number of samples from each group is indicated in the brackets at the bottom of the graph. The results are expressed as means ± SEMs. RFU: relative fluorescence units.
Figure 7 Effect of serum from COPD patients and healthy volunteers on the secretion of VEGF (A–C) CXCL8/IL-8 (D–F) and CXCL5 (G–I) depending on smoking status, stage of obstruction, and COPD group by bronchial epithelial cells, respectively. The number of samples from each group is indicated in the brackets at the bottom of the graph. The results are expressed as means ± SEMs. RFU: relative fluorescence units.CC BY · PubMed Central
Figure 8 Effect of serum from COPD patients and healthy volunteers on adhesion (A) proliferation (B) and migration (C) of A549 lung cancer cells. Adhesion was tested in the presence of epithelial cells exposed to both types of serum. The proliferation and migration of cancer cells were analyzed through their exposure to conditioned medium generated by the epithelial cells subjected to the sera. The results are expressed as means ± SEMs. RFU: relative fluorescence units.
Figure 8 Effect of serum from COPD patients and healthy volunteers on adhesion (A) proliferation (B) and migration (C) of A549 lung cancer cells. Adhesion was tested in the presence of epithelial cells exposed to both types of serum. The proliferation and migration of cancer cells were analyzed through their exposure to conditioned medium generated by the epithelial cells subjected to the sera. The results are expressed as means ± SEMs. RFU: relative fluorescence units.CC BY · PubMed Central
Figure 9 Effect of conditioned medium generated by epithelial cells subjected to serum from COPD patients and healthy volunteers, and by replicatively senescent epithelial cells (Sen) on proliferation (A) and migration (B) of A549 lung cancer cells. The results are expressed as means ± SEMs. RFU: relative fluorescence units.
Figure 9 Effect of conditioned medium generated by epithelial cells subjected to serum from COPD patients and healthy volunteers, and by replicatively senescent epithelial cells (Sen) on proliferation (A) and migration (B) of A549 lung cancer cells. The results are expressed as means ± SEMs. RFU: relative fluorescence units.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Cited by

See all 25

Metadata

Authors
Kuźnar-Kamińska, B., Mikuła-Pietrasik, J., Witucka, A., Romaniuk, A., Konieczna, N., Rubiś, B., Książek, K., Tykarski, A., & Batura-Gabryel, H.
Affiliations
Poznan University of Medical Sciences (PL)
Corresponding author
Kuźnar-Kamińska, Barbara
Venue
Scientific Reports
Published
2018-08-28
Volume
8
Issue
1
Pages
12940-12940
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2888014098
Cited by
22
References
38
Citations by year
2026: 2 · 2025: 4 · 2024: 5 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 4 · 2019: 1 · 2018: 2
FWCI
1.38
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Narodowym Centrum Nauki (2016/21/B/NZ7/01079)
  • Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu (2016/21/B/NZ7/01079)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Keywords
chronic obstructive pulmonary disease, cellular senescence, bronchial epithelial cells, lung cancer progression, reactive oxygen species, CXCL5, interleukin-8, vascular endothelial growth factor, cancer cell proliferation and migration, smoking, p21
MeSH terms
Aged, Aged, 80 and over, Antigens, Differentiation, Bronchi, Cells, Cultured, Epithelial Cells, Female, Humans, Male, Middle Aged, Cytokines, Cellular Senescence, Pulmonary Disease, Chronic Obstructive, Serum

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum from patients with chronic obstructive pulmonary disease induces senescence-related phenotype in bronchial epithelial cells. https://app.cochat.ai/papers/10.1038/s41598-018-31037-w
The paper
Kuźnar-Kamińska, B., Mikuła-Pietrasik, J., Witucka, A., Romaniuk, A., Konieczna, N., Rubiś, B., Książek, K., Tykarski, A., & Batura-Gabryel, H. (2018). Serum from patients with chronic obstructive pulmonary disease induces senescence-related phenotype in bronchial epithelial cells. Scientific Reports. https://doi.org/10.1038/s41598-018-31037-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.